These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 25597008)

  • 1. Synthesis and properties of vitamin E analog-conjugated neomycin for delivery of RNAi drugs to liver cells.
    Iwata R; Nakayama F; Hirochi S; Sato K; Piao W; Nishina K; Yokota T; Wada T
    Bioorg Med Chem Lett; 2015 Feb; 25(4):815-9. PubMed ID: 25597008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and properties of double-stranded RNA-bindable oligodiaminogalactose derivatives conjugated with vitamin E.
    Iwata R; Nishina K; Yokota T; Wada T
    Bioorg Med Chem; 2014 Feb; 22(4):1394-403. PubMed ID: 24462177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structurally modulated codelivery of siRNA and Argonaute 2 for enhanced RNA interference.
    Li J; Wu C; Wang W; He Y; Elkayam E; Joshua-Tor L; Hammond PT
    Proc Natl Acad Sci U S A; 2018 Mar; 115(12):E2696-E2705. PubMed ID: 29432194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of apoptosis in the liver by systemic and local delivery of small-interfering RNAs.
    Zender L; Kubicka S
    Methods Mol Biol; 2007; 361():217-26. PubMed ID: 17172714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant Dicer efficiently converts large dsRNAs into siRNAs suitable for gene silencing.
    Myers JW; Jones JT; Meyer T; Ferrell JE
    Nat Biotechnol; 2003 Mar; 21(3):324-8. PubMed ID: 12592410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in siRNA delivery.
    Sarisozen C; Salzano G; Torchilin VP
    Biomol Concepts; 2015 Dec; 6(5-6):321-41. PubMed ID: 26609865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs.
    Aigner A
    J Biotechnol; 2006 Jun; 124(1):12-25. PubMed ID: 16413079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid-conjugated 27-nucleotide double-stranded RNAs with dicer-substrate potency enhance RNAi-mediated gene silencing.
    Kubo T; Yanagihara K; Takei Y; Mihara K; Sato Y; Seyama T
    Mol Pharm; 2012 May; 9(5):1374-83. PubMed ID: 22494497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-stranded RNA-binding artificial cationic oligosaccharides stabilizing siRNAs with a low N/P ratio.
    Hara RI; Maeda Y; Sakamoto T; Wada T
    Org Biomol Chem; 2017 Feb; 15(7):1710-1717. PubMed ID: 28138666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic potential of RNA interference against cancer.
    Takeshita F; Ochiya T
    Cancer Sci; 2006 Aug; 97(8):689-96. PubMed ID: 16863503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Target delivery of small interfering RNAs with vitamin E-coupled nanoparticles for treating hepatitis C.
    Duan L; Yan Y; Liu J; Wang B; Li P; Hu Q; Chen W
    Sci Rep; 2016 Apr; 6():24867. PubMed ID: 27113197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Running interference: prospects and obstacles to using small interfering RNAs as small molecule drugs.
    Dykxhoorn DM; Lieberman J
    Annu Rev Biomed Eng; 2006; 8():377-402. PubMed ID: 16834561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrodynamic delivery protocols.
    Rychahou PG; Evers BM
    Methods Mol Biol; 2010; 623():189-95. PubMed ID: 20217552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of modified double stranded RNAs containing duplex regions between amide-linked RNA and RNA at both ends and enhanced nuclease resistance.
    Iwase R; Kurokawa R; Ueno J
    Nucleic Acids Symp Ser (Oxf); 2009; (53):119-20. PubMed ID: 19749289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. siRNAs: their potential as therapeutic agents--Part II. Methods of delivery.
    Singh SK; Hajeri PB
    Drug Discov Today; 2009 Sep; 14(17-18):859-65. PubMed ID: 19540929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous siRNAs from naturally formed dsRNAs regulate transcripts in mouse oocytes.
    Watanabe T; Totoki Y; Toyoda A; Kaneda M; Kuramochi-Miyagawa S; Obata Y; Chiba H; Kohara Y; Kono T; Nakano T; Surani MA; Sakaki Y; Sasaki H
    Nature; 2008 May; 453(7194):539-43. PubMed ID: 18404146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of simple and efficient DNA vector-based short hairpin RNA expression systems for specific gene silencing in mammalian cells.
    Cheng TL; Chang WT
    Methods Mol Biol; 2007; 408():223-41. PubMed ID: 18314586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and properties of 4'-C-aminoalkyl-2'-fluoro-modified RNA oligomers.
    Kano T; Katsuragi Y; Maeda Y; Ueno Y
    Bioorg Med Chem; 2018 Aug; 26(15):4574-4582. PubMed ID: 30097362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyethylenimines for RNAi-mediated gene targeting in vivo and siRNA delivery to the lung.
    Günther M; Lipka J; Malek A; Gutsch D; Kreyling W; Aigner A
    Eur J Pharm Biopharm; 2011 Apr; 77(3):438-49. PubMed ID: 21093588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional comparison of single- and double-stranded siRNAs in mammalian cells.
    Xu Y; Linde A; Larsson O; Thormeyer D; Elmen J; Wahlestedt C; Liang Z
    Biochem Biophys Res Commun; 2004 Apr; 316(3):680-7. PubMed ID: 15033453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.